Tuttle Capital Management, LLC Edwards Lifesciences Corp Transaction History

Tuttle Capital Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 11, 2020	SELL	$57.54 - $76.95 $598,991 - $801,049	-10,410 Closed	0 $0
Q1 2020 Apr 09, 2020	BUY	$52.41 - $81.0 $196,380 - $303,507	3,747 Added 56.24%	10,410 $1.96 Million
Q4 2019 Jan 13, 2020	BUY	$71.7 - $82.09 $477,737 - $546,965	6,663 New	6,663 $1.55 Million
Q2 2019 Jul 29, 2019	SELL	$55.74 - $64.41 $685,936 - $792,629	-12,306 Closed	0 $0
Q1 2019 May 10, 2019	BUY	$47.89 - $64.05 $589,334 - $788,199	12,306 New	12,306 $2.36 Million

1,351

455M

9.76M

3.92M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $41.9B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Tuttle Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Tuttle Capital Management, LLC with notifications on news.